Inpixon Reports First Quarter 2022 Financial Results and Provides Business Update

<br /> Inpixon Reports First Quarter 2022 Financial Results and Provides Business Update<br />

PR Newswire


Achieves 77% Increase in Revenue Versus the Same Period Last Year


Conference Call to be Held Today at

4:30 p.m. Eastern Time



PALO ALTO, Calif.


,


May 16, 2022


/PRNewswire/ — Inpixon® (Nasdaq: INPX), the Indoor Intelligence® company, today provided a business update and reported financial results for its 2022 first quarter ended

March 31, 2022

.

“I’m pleased to report that we continued our strong revenue growth in the first quarter of 2022, as illustrated by a 77% increase in revenue to

$5.2 million

as compared to

$3.0 million

for the same period in 2021,” commented

Nadir Ali

, CEO of Inpixon. “This growth results from Inpixon’s ability to continue to add household name-brand enterprise organizations to its Indoor Intelligence customer list. Our enterprise app platforms are designed to meet the needs of the modern organization, providing a smart, innovative and connected space with technologies that provide end-to-end logistics, management tools and analytics for the workplace, events, and customer experience programs. Our customers are choosing us because we can deliver an enterprise-level platform, rich with over 150 workplace features and partnerships that allow for over 75 enterprise software integrations.

We are at the forefront of delivering solutions that are focused on interconnectivity, automation and intelligence driven by better, more reliable data. With our breadth of hardware and software technologies, Inpixon is well positioned to take advantage of not only the market growth in hybrid workplaces, hybrid events and industrial automation but also the metaverse. Inpixon has the foundational technologies and skillsets — in hardware design, software development, wireless communications, mapping, positioning, augmented reality, computer vision, 3D rendering, advanced visualizations, analytics, and artificial intelligence — to ride the metaverse wave.

“Inpixon technologies are gaining broad recognition as a leader in the market, with numerous industry awards and

media coverage

. We believe we have a solid foundation for continued growth and look forward to expanding our partnerships with organizations that share a vision for driving change and reimagining workplace experiences,” concluded Mr. Ali.


Recent Highlights:


  • Rebranded

    CXApp products to Inpixon Experience, Inpixon Events and Inpixon CX Briefing
  • Secured multiple new contracts with Fortune 1000-ranked organizations

  • Completed


    $50 million

    registered direct offering

  • Ranked

    number one for RTLS Use Case in 2022 Gartner® Critical Capabilities for Indoor Location Services report[1]


Financial Results

Revenues for the three months ended

March 31, 2022

were

$5.2 million

compared to

$3.0 million

for the comparable period in the prior year for an increase of approximately

$2.3 million

, or approximately 77%. This increase is primarily attributable to the increase in Indoor Intelligence sales, particularly our enterprise app (CXApp) product line which was acquired during the second quarter of 2021 and the addition of the IIoT product line in the fourth quarter of 2021. Gross profit for the three months ended

March 31, 2022

, was

$3.8 million

compared to

$2.1 million

for the comparable period in the prior year, an increase of 86%. The gross profit margin for the three months ended

March 31, 2022

was 73% compared to 70% for the three months ended

March 31, 2021

. Net income or loss attributable to stockholders of Inpixon three months ended

March 31, 2022

was a loss of

$11.2 million

compared to a loss of

$12.6 million

for the comparable period in the prior year. This decrease in loss of approximately

$1.3 million

was primarily attributable to increased gross profit of

$1.8 million

, lower operating costs of

$0.6 million

and higher non-controlling interest of

$0.4 million

offset by the

$1.5 million

unrealized loss on the Sysorex shares.

Non-GAAP Adjusted EBITDA for the three months ended

March 31, 2022

, was a loss of

$8.8 million

compared to a loss of

$5.6 million

for the prior year period. EBITDA is defined as net income (loss) before interest, provision for income taxes, and depreciation and amortization. Adjusted EBITDA is used by Inpixon management as a metric by which it manages the business. It is defined as EBITDA plus adjustments for other income or expense items, non-recurring items and other non-cash items including stock-based compensation.

Proforma non-GAAP net loss per basic and diluted common share for the three months ended

March 31, 2022

was a loss of

($0.07)

compared to a loss of

($0.08)

per share for the prior year period. Proforma non-GAAP net income (loss) per share is used by Inpixon management as an evaluation tool as it manages the business and is defined as net income (loss) per basic and diluted share adjusted for non-cash items including stock-based compensation, amortization of intangibles and one-time charges and other adjustments including provision for valuation allowances, severance costs, acquisition costs and costs associated with public offerings.


Conference Call

Inpixon management will host a conference call today at

4:30 PM Eastern Time

to discuss the company’s financial results for the first quarter ended

March 31, 2022

, as well as to review the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll-free 844-602-0380 for U.S. callers or +1 862-298-0970 for international callers. A webcast of the call may be accessed at

https://www.webcaster4.com/Webcast/Page/2235/45553

or on the company’s Investors section of the website:

ir.inpixon.com

.

Investors and other interested parties are invited to submit questions to management prior to the call’s start via email to

[email protected].

A webcast replay will be available on the company’s Investors section of the website (

ir.inpixon.com

) through

May 16, 2023

. A telephone replay of the call will be available approximately one hour following the call, through

May 23, 2022

, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering conference ID: 45553.

[1] Gartner, Critical Capabilities for Indoor Location Services,

Tim Zimmerman

,

Annette Zimmermann

, 7 March 2022.


Gartner Disclaimer

Gartner and Magic Quadrant are registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.


About Inpixon

Inpixon® (Nasdaq: INPX) is the innovator of Indoor Intelligence®, delivering actionable insights for people, places and things. Combining the power of mapping, positioning and analytics, Inpixon helps to create smarter, safer, and more secure environments. The company’s Indoor Intelligence and mobile app solutions are leveraged by a multitude of industries to optimize operations, increase productivity, and enhance safety. Inpixon customers can take advantage of industry leading location awareness, RTLS, workplace and hybrid event solutions, analytics, sensor fusion, IIoT and the IoT to create exceptional experiences and to do good with indoor data. For the latest insights, follow Inpixon on

LinkedIn

, and

Twitter

, and visit

inpixon.com

.


Safe Harbor Statement


All statements in this release that are not based on historical fact are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the control of Inpixon and its subsidiaries, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of economic conditions, the impact of COVID-19, global conflicts, inflation and other global events on Inpixon’s results of operations and global supply chain constraints, Inpixon’s ability to integrate the products and business from recent acquisitions into its existing business, the performance of management and employees, the regulatory landscape as it relates to privacy regulations and their applicability to Inpixon’s technology, Inpixon’s ability to maintain compliance with Nasdaq’s minimum bid price requirement and other continued listing requirements, the ability to obtain financing if needed, competition, general economic conditions and other factors that are detailed in Inpixon’s periodic and current reports available for review at sec.gov. Furthermore, Inpixon operates in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. Inpixon disclaims any intention to, and undertakes no obligation to, update or revise forward-looking statements.


Non-GAAP Financial Measures

Management believes that certain financial measures not in accordance with generally accepted accounting principles in the United States (“GAAP”) are useful measures of operations. EBIDTA, Adjusted EBITDA and pro forma net loss per share are non-GAAP measures. Inpixon defines “EBITDA” as net income (loss) before interest, provision for (benefit from) income taxes, and depreciation and amortization. Management uses Adjusted EBITDA as a metric for which it manages the business, and Inpixon defines “Adjusted EBITDA” as EBITDA plus adjustments for other income or expense items, non-recurring items and non-cash items. Inpixon defines “pro forma net loss per share” as GAAP net loss per share adjusted for stock-based compensation, amortization of intangibles and one-time charges including loss on the exchange of debt for equity and provision for valuation allowances.

Management provides Adjusted EBITDA and pro forma net loss per share measures so that investors will have the same financial information that management uses, which may assist investors in assessing Inpixon’s performance on a period-over-period basis. Adjusted EBITDA or pro forma net loss per share is not a measure of financial performance under GAAP, and should not be considered an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA and pro forma net loss per share have limitations as analytical tools and should not be considered either in isolation or as a substitute for analysis of Inpixon’s results as reported under GAAP.

For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, please see the “Reconciliation of Non-GAAP Financial Measures” table accompanying this press release.


Inpixon Contacts


General inquiries:


Inpixon

Email:

[email protected]


Web:



inpixon.com/contact-us


Media relations:


Offleash PR for Inpixon

Email:

[email protected]


Investor relations:


Crescendo Communications, LLC

Tel: +1 212-671-1020

Email:

[email protected]




INPIXON AND SUBSIDIARIES




CONDENSED CONSOLIDATED BALANCE SHEETS



(In thousands, except number of shares and par value data)


As of


March 31,

2022


December 31,

2021


(Unaudited)


(Audited)



ASSETS



Current Assets


Cash and cash equivalents


$


60,852


$


52,480


Accounts receivable, net of allowances of $272 and $272, respectively


3,454


3,218


Notes and other receivables


284


321


Inventory, net of reserve of $438 and $438, respectively


1,766


1,976


Short-term investments


15,035


43,125


Prepaid assets and other current assets


8,474


4,842



Total Current Assets


89,865


105,962


Property and equipment, net


1,412


1,442


Operating lease right-of-use asset, net


1,558


1,736


Software development costs, net


1,688


1,792


Investment in Equity Securities


335


1,838


Long-term investments


2,500


2,500


Intangible assets, net


32,002


33,478


Goodwill


7,656


7,672


Other assets


209


253



Total Assets


$


137,225


$


156,673



LIABILITIES AND STOCKHOLDERS’ EQUITY



Current Liabilities


Accounts payable


$


1,066


$


2,414


Accrued liabilities


3,863


10,665


Operating lease obligation, current


619


643


Deferred revenue


4,133


4,805


Short-term debt


2,411


3,490


Acquisition liability


3,436


5,114



Total Current Liabilities


15,528


27,131



Long Term Liabilities


Operating lease obligations, noncurrent


982


1,108


Other liabilities, noncurrent


28


28


Acquisition liability, noncurrent


110


220



Total Liabilities


16,648


28,487



Commitments and Contingencies



Mezzanine Equity


Series 7 Convertible Preferred Stock – 58,750 shares authorized; zero and 49,250 issued and outstanding as of March 31, 2022 and December 31, 2021, respectively.




44,695


Series 8 Convertible Preferred Stock – 53,197.7234 shares authorized; 53,197.7234 and zero issued and outstanding as of March 31, 2022 and December 31, 2021, respectively. (Liquidation preference of $53,197,723)


43,173





Stockholders’ Equity


Preferred Stock – $0.001 par value; 5,000,000 shares authorized;


Series 4 Convertible Preferred Stock – 10,415 shares authorized; 1 issued, and 1 outstanding as of March 31, 2022 and December 31, 2021, respectively;






Series 5 Convertible Preferred Stock – 12,000 shares authorized; 126 issued, and 126 outstanding as of March  31, 2022 and December 31, 2021, respectively.






Common Stock – $0.001 par value; 2,000,000,000 shares authorized;

152,476,356 and 124,440,924 issued and 152,476,355 and 124,440,923

outstanding as of March 31, 2022 and December 31, 2021, respectively.


152


124


Additional paid-in capital


338,183


332,639


Treasury stock, at cost, 1 share


(695)


(695)


Accumulated other comprehensive income


(58)


44


Accumulated deficit


(261,535)


(250,309)


Stockholders’ Equity Attributable to Inpixon


76,047


81,803


Non-controlling interest


1,357


1,688



Total Stockholders’ Equity


77,404


83,491



Total Liabilities, Mezzanine Equity and Stockholders’ Equity


$


137,225


$


156,673



INPIXON AND SUBSIDIARIES



CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS



(In thousands, except per share data)


For the Three Months


March 31,


2022


2021


(Unaudited)



Revenues


$


5,231


$


2,954



Cost of Revenues


1,386


884



Gross Profit


3,845


2,070



Operating Expenses


Research and development


4,085


2,708


Sales and marketing


2,276


1,639


General and administrative


6,105


9,171


Acquisition related costs


121


470


Amortization of intangibles


1,322


502



Total Operating Expenses


13,909


14,490



Loss from Operations


(10,064)


(12,420)



Other Income (Expense)


Interest expense, net


2


(349)


Loss on exchange of debt for equity




(30)


Benefit (provision) for valuation allowance on related party loan – held for sale




(117)


Other income


108


386


Unrealized loss on equity securities


(1,503)





Total Other Income (Expense)


(1,393)


(110)



Net Loss, before tax


(11,457)


(12,530)


Income tax provision


(100)


(9)



Net Loss


(11,557)


(12,539)



Net (Loss) Income Attributable to Non-controlling Interest


(346)


18



Net Loss Attributable to Stockholders of Inpixon


(11,211)


(12,557)


Accretion of Series 7 preferred stock


(4,555)




Accretion of Series 8 Preferred Stock


(548)




Deemed dividend for the modification related to Series 8 Preferred Stock


(2,627)




Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock


1,469




Amortization premium- modification related to Series 8 Prefered Stock


110





Net Loss Attributable to Common Stockholders


$


(17,362)


$


(12,557)



Net Loss Per Share – Basic and Diluted


$


(0.13)


$


(0.16)



Weighted Average Shares Outstanding


Basic and Diluted


138,502,493


78,942,697



Comprehensive Loss


Net Loss


$


(11,557)


$


(12,539)


Unrealized foreign exchange loss from cumulative translation adjustments


(102)


(671)



Comprehensive Loss


$


(11,659)


$


(13,210)



INPIXON AND SUBSIDIARIES



CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS



(In thousands)


For the Three Months Ended,


March 31,


2022


2021


(Unaudited)



Cash Flows Used In Operating Activities


Net loss


$


(11,557)


$


(12,539)


Adjustments to reconcile net loss to net cash used in operating activities:


Depreciation and amortization


317


293


Amortization of intangible assets


1,489


650


Amortization of right of use asset


169


181


Stock based compensation


1,533


5,096


Earnout payment expense


(2,827)




Loss on exchange of debt for equity




30


Amortization of debt discount




224


Related party note, gain on foreign currency transaction




(363)


Unrealized gain on note


(167)




Provision for the valuation allowance for held for sale loan




117


Income tax expense




9


Unrealized loss on equity securities


1,503




Other


146




Changes in operating assets and liabilities:


Accounts receivable and other receivables


(239)


426


Inventory


181


(279)


Prepaid expenses and other current assets


(3,607)


135


Other assets


41


(227)


Accounts payable


(1,345)


480


Accrued liabilities


(109)


421


Income tax liabilities


(40)




Deferred revenue


(666)


(235)


Operating lease obligation


(141)


(176)


Other liabilities




96



Net Cash Used in Operating Activities


$


(15,319)


$


(5,661)



Cash Flows Used in Investing Activities


Purchase of property and equipment


(81)


(109)


Purchases of capitalized software


(107)


(253)


Investments in short term investments




(42,059)


Sales of treasury bills


28,001




Purchase of Systat licensing agreement




(900)



Net Cash Provided By (Used in) Investing Activities


$


27,813


$


(43,321)



Cash From Financing Activities


Net proceeds from issuance of preferred stock and warrants


$


46,906


$




Net proceeds from issuance of common stock and warrants




77,853


Cash paid for redemption of preferred stock series 7


(49,250)




Restricted stock forfeiture for settlement of employee taxes


(336)




Loans to related party




(117)


Net proceeds from promissory notes


364




Repayment of CXApp acquisition liability


(1,787)




Repayment of acquisition liability to Locality shareholders




(467)



Net Cash (Used In) Provided By Financing Activities


$


(4,103)


$


77,269



Effect of Foreign Exchange Rate on Changes on Cash


(19)


(10)



Net Increase in Cash and Cash Equivalents


8,372


28,277


Cash and Cash Equivalents – Beginning of period


52,480


17,996


Cash and Cash Equivalents  – End of period


$


60,852


$


46,273



Reconciliation of Non-GAAP Financial Measures:



For the Three Months Ended,


(In thousands)



March 31,



2022



2021


Net loss attributable to common stockholders


$      (17,362)


$              (12,557)


Adjustments:


Non-recurring one-time charges:


Loss on exchange of debt for equity




30


Provision for valuation allowance on held for sale loan




117


Unrealized loss on equity securities


1,503




Acquisition transaction/financing costs


121


470


Earnout compensation benefit


(2,827)




Accretion of series 7 preferred stock


4,555




Accretion of series 8 preferred stock


548




Deemed dividend for the modification related to Series 8 Preferred Stock


2,627




Deemed contribution for the modification related to warrants issued in connection with Series 8 Preferred Stock


(1,469)




Amortization premium- modification related to Series 8 Prefered Stock


(110)




Professional service fees


8


349


Unrealized losses/(gains) on notes, loans, investments


89


(363)


Stock-based compensation – compensation and related benefits


1,533


5,096


Severance costs


111




Interest (income)/expense, net


(2)


349


Income tax provision


100


9


Depreciation and amortization


1,806


943


Adjusted EBITDA


$        (8,769)


$                (5,557)



For the Three Months Ended,


(In thousands, except share data)



March 31,



2022



2021


Net loss attributable to common stockholders


$      (17,362)


$              (12,557)


Adjustments:


Non-recurring one-time charges:


Loss on exchange of debt for equity




30


Provision for valuation allowance on held for sale loan




117


Unrealized loss on equity securities


1,503




Acquisition transaction/financing costs


121


470


Earnout compensation benefit


(2,827)




Accretion of series 7 preferred stock


4,555




Accretion of series 8 preferred stock


548




Deemed dividend for the modification related to Series 8 Preferred Stock


2,627




Deemed contribution for the modification related to warrants issued in connection with Series 8 Preferred Stock


(1,469)




Amortization premium- modification related to Series 8 Prefered Stock


(110)




Professional service fees


8


349


Unrealized losses/(gains) on investments


89


(363)


Stock-based compensation – compensation and related benefits


1,533


5,096


Severance costs


111




Amortization of intangibles


1,489


650


Proforma non-GAAP net loss


$        (9,184)


$                (6,208)


Proforma non-GAAP net loss per basic and diluted common share


$          (0.07)


$                  (0.08)


Weighted average basic and diluted common shares outstanding


138,502,493


78,942,697

Cision
View original content to download multimedia:

https://www.prnewswire.com/news-releases/inpixon-reports-first-quarter-2022-financial-results-and-provides-business-update-301548335.html

SOURCE Inpixon